|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600118975 |
|
最近更新日期: Date of Last Refreshed on: |
2026-02-13 14:37:10 |
|
注册时间: Date of Registration: |
2026-02-13 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
智能可拆卸式分体牙垫的研制与临床应用 |
|
Public title: |
Development and clinical application of intelligent detachable split tooth pad |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
智能可拆卸式分体牙垫的研制与临床应用 |
|
Scientific title: |
Development and clinical application of intelligent detachable split tooth pad |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王振 |
研究负责人: |
王振 |
|
Applicant: |
Wang Zhen |
Study leader: |
Wang Zhen |
|
申请注册联系人电话: Applicant telephone: |
+86 573 82519999 |
研究负责人电话:
Study leader's |
+86 573 82519999 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
649948565@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
649948565@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省嘉兴市南湖区中环南路1882号 |
研究负责人通讯地址: |
浙江省嘉兴市南湖区中环南路1882号 |
|
Applicant address: |
No. 1882, South Zhonghuan Road, Nanhu District, Jiaxing City, Zhejiang Province |
Study leader's address: |
No. 1882, South Zhonghuan Road, Nanhu District, Jiaxing City, Zhejiang Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
嘉兴市第一医院 |
||
|
Applicant's institution: |
The First Hospital of Jiaxing |
||
|
研究负责人所在单位: |
嘉兴市第一医院 |
||
|
Affiliation of the Leader: |
The First Hospital of Jiaxing |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025-LP-259 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
嘉兴市第一医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Jiaxing First Hospital Medical Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-21 00:00:00 | ||
|
伦理委员会联系人: |
许文 |
||
|
Contact Name of the ethic committee: |
Xu Wen |
||
|
伦理委员会联系地址: |
浙江省嘉兴市南湖区中环南路1882号 |
||
|
Contact Address of the ethic committee: |
No. 1882, South Zhonghuan Road, Nanhu District, Jiaxing City, Zhejiang Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 573 89976378 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
xwkikimi@163.com |
|
研究实施负责(组长)单位: |
嘉兴市第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Hospital of Jiaxing |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省嘉兴市南湖区中环南路1882号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1882, South Zhonghuan Road, Nanhu District, Jiaxing City, Zhejiang Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
浙江省卫生健康行业科技计划 |
||||||||||||||||||||||
|
Source(s) of funding: |
Science and Technology Plan for the Health and Wellness Industry of Zhejiang Province |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
1新产品研发。基于现有牙垫结构,研发新的智能化牙垫,集成高灵敏度咬合力监测模块,实时监测咬合力并传输至服务端,探索应用于“镇静效果监测、力学监测及防意外拔管”等场景; 2 客观数据构建疼痛评分新标准。以咬合力客观数据代替主观镇静镇痛效果评分,构建新的标准并分析其实用性; 3 成果应用推广。协助转化公司进行推广,通过本试验明确其在“口腔护理工时、咽部细菌定植情况、口腔Beck评分、VAP发生率、气管插管刻度偏移、家属满意度”等方面的效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. New product development. Based on the existing dental pad structure, develop a new intelligent dental pad that integrates a high-sensitivity bite force monitoring module, capable of real-time bite force monitoring and transmission to the server, exploring applications in scenarios such as 'sedation effect monitoring, mechanical monitoring, and prevention of accidental tube dislodgement'; 2. Construct new standards for pain scoring using objective data. Replace subjective sedation and analgesia effect scores with objective bite force data, establish new standards, and analyze their practicality; 3. Promotion and application of results. Assist the company in promotion, and through this trial, clarify its effects on 'oral care work hours, pharyngeal bacterial colonization, oral Beck scores, VAP incidence, tracheal tube displacement, and family satisfaction.' |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.气管插管; 2.年龄>=18周岁; 3.口腔内无明显损伤; 4.临床资料完整; 5.授权人对本研究知情同意. |
||||||||||||||||||||||
|
Inclusion criteria |
1. Endotracheal intubation; 2. Age >= 18 years; 3. No obvious oral cavity injuries; 4. Complete clinical data; 5. Authorized person has provided informed consent for this study. |
||||||||||||||||||||||
|
排除标准: |
1.口腔内已有损伤; 2.择期手术,预计七天内转出ICU; 3.合并器官移植、粒细胞减少症、恶性肿瘤晚期等严重免疫功能抑制者; 4.近3个月内使用免疫抑制剂、糖皮质激素; 5.严重躁动患者,RASS评分>=4分. |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Existing oral cavity lesions; 2. Elective surgery, ICU transfer expected within seven days; 3. Patients with severe immunosuppression, such as organ transplant recipients, neutropenia, or advanced malignant tumors; 4. Use of immunosuppressants or glucocorticoids within the past three months; 5. Patients with severe agitation, RASS score >= 4. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-03-01 00:00:00至 To 2028-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-03-01 00:00:00 至 To 2027-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由项目负责人用Excel进行简单随机法产生数列 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Generated sequence by the project leader using Excel's simple random method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
对参试者设盲 |
|
Blinding: |
Blind the participants |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
无 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
None |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |